Melanoma immunotherapy: a battle against radicals?

被引：12

作者：

Hellstrand, K ^{[1
]}

机构：

[1] Univ Gothenburg, Dept Virol, S-41346 Gothenburg, Sweden

来源：

TRENDS IN IMMUNOLOGY | 2003年 / 24卷 / 05期

关键词：

D O I：

10.1016/S1471-4906(03)00070-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：232 / 233

页数：2

共 8 条

[1] Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma [J].

Agarwala, SS ;

Glaspy, J ;

O'Day, SJ ;

Mitchell, M ;

Gutheil, J ;

Whitman, E ;

Gonzalez, R ;

Hersh, E ;

Feun, L ;

Belt, R ;

Meyskens, F ;

Hellstrand, K ;

Wood, D ;

Kirkwood, JM ;

Gehlsen, KR ;

Naredi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :125-133

[2]

Hansson M, 1996, J IMMUNOL, V156, P42

[3]

HELLSTRAND K, 1994, J IMMUNOL, V153, P4940

[4] Tumor-induced immune dysfunction [J].

Kiessling, R ;

Wasserman, K ;

Horiguchi, S ;

Kono, K ;

Sjöberg, J ;

Pisa, P ;

Petersson, M .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (07) :353-362

[5] Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity [J].

Kono, K ;

SalazarOnfray, F ;

Petersson, M ;

Hansson, J ;

Masucci, G ;

Wasserman, K ;

Nakazawa, T ;

Anderson, P ;

Kiessling, R .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1308-1313

[6] Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes [J].

Mantovani, A ;

Sozzani, S ;

Locati, M ;

Allavena, P ;

Sica, A .

TRENDS IN IMMUNOLOGY, 2002, 23 (11) :549-555

[7] ALTERATIONS IN THE SIGNAL-TRANSDUCING MOLECULES OF T-CELLS AND NK CELLS IN COLORECTAL TUMOR-INFILTRATING, GUT MUCOSAL AND PERIPHERAL LYMPHOCYTES - CORRELATION WITH THE STAGE OF THE DISEASE [J].

MATSUDA, M ;

PETERSSON, M ;

LENKEI, R ;

TAUPIN, JL ;

MAGNUSSON, I ;

MELLSTEDT, H ;

ANDERSON, P ;

KIESSLING, R .

INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (06) :765-772

[8]

Zea AH, 1995, CLIN CANCER RES, V1, P1327

← 1 →